ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033

SAN DIEGO, Sept. 16, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”), today announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal amount […]

News

Joel Yuen-Zhou Named Blavatnik Finalist

UC San Diego Professor of Chemistry Joel Yuen-Zhou is 1 of 18 finalists for the 2026 Blavatnik National Awards for Young Scientists. The highly coveted awards recognize exceptional early career scientists and engineers whose discoveries […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ClearNote Health to Showcase Power of 5hmC Signatures for Treatment Monitoring at AACR Conference on Pancreatic Cancer

SAN DIEGO–(BUSINESS WIRE)– #5hmC–ClearNote Health will present new data for its Avantect® Pancreatic Cancer Test and its Virtuoso® platform at the AACR Conference on Pancreatic Cancer Click here to view original post Click Here to […]


ADVERTISEMENT — Advertise With Biotech Networks
News

LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation

SAN DIEGO, Sept. 15, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT). NASDAQ: PRCT investors should contact the Shareholders […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
San Diego Biotech Jobs

Bioinformatics Associate – San Diego, CA 92127

Job details   Pulled from the full job description 401(k) Health insurance 401(k) matching Paid time off Vision insurance Dental insurance   Job Title: Bioinformatics Associate Company Name: GeneGoCell Inc. … Click here to view […]

News

NASDAQ: CAPR LAWSUIT ALERT: Investors who lost money with shares of Capricor Therapeutics, Inc.should contact the Shareholders Foundation

SAN DIEGO, Sept. 15, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR). NASDAQ: CAPR investors should contact the Shareholders […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Drug Discovery

Consolidating Antibody Discovery Data with an AI Platform

FairJourney Bio (FJBio) selected the Sapio Scientific AI platform, including Sapio’s LIMS, ELN, and AI co-scientist solutions to replace spreadsheet-based records and manual reporting processes across its international operations. FJBio is a global antibody discovery […]

No Picture
News

Amprion Launches SAAmplify®-?SYN Plus: The First & Only Commercially Available CSF Test to Detect Alpha-Synuclein Profile for Multiple System Atrophy

SAN DIEGO–(BUSINESS WIRE)–Amprion Launches SAAmplify®-?SYN Plus: The First & Only Commercially Available CSF Test to Detect Alpha-Synuclein Profile for Multiple System Atrophy Click here to view original post Click Here to Publish/Feature Your Company or […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder

SAN DIEGO–(BUSINESS WIRE)–Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that the MOONLIGHT-1 trial […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biotechnology company developing tumor-activated immunotherapies, today announced that the first patient has been dosed in the Phase 1 clinical trial evaluating JANX013, Janux’s novel PSMA-targeted tumor-activated […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CARLSBAD, Calif., Sept. 14, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced […]

No Picture
San Diego Biotech Jobs

Lab Technician | San Diego

About Plasmidsaurus Plasmidsaurus is on a mission to accelerate new cures and promote a healthier planet by unlocking a… Click here to view original post